Histopathologically confirmed advanced cancer (colorectal cancer, head and neck squamous cell cancer, non-small cell lung cancer and gastric cancer (including gastroesophageal junction cancer))
Prior treatment with at least one line of cytotoxic systemic therapy for metastatic/unresectable cancer
Adult patients (≥18 years of age)
Must be willing to comply with study procedures
You may not be if
History or presence of any clinically significant disorders as judged by the Investigator.
Clareo Health | Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
